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Abstract
We found that B-lapachone (B-lap), a novel bioreductive
drug, caused rapid apoptosis and clonogenic cell death
in A549 human lung epithelial cancer cells in vitro in
a dose-dependent manner. The clonogenic cell death
caused by B-lap could be significantly inhibited by
dicoumarol, an inhibitor of NAD(P)H:quinone oxido-
reductase (NQO1), and also by siRNA for NQO1, dem-
onstrating that NQO1-induced bioreduction of B-lap is
an essential step in B-lap–induced cell death. Irradia-
tion of A549 cells with 4 Gy caused a long-lasting
upregulation of NQO1, thereby increasing NQO1-
mediated B-lap–induced cell deaths. Although the di-
rect cause of B-lap–induced apoptosis is not yet clear,
B-lap treatment reduced the expression of p53 and
NF-KB, whereas it increased cytochrome C release,
caspase-3 activity, and ;H2AX foci formation. Impor-
tantly, B-lap treatment immediately after irradiation en-
hanced radiation-induced cell death, indicating that
B-lap sensitizes cancer cells to radiation, in addition to
directly killing some of the cells. The growth of A549
tumors induced in immunocompromised mice could
be markedly suppressed by local radiation therapy
when followed by B-lap treatment. This is the first
study to demonstrate that combined radiotherapy and
B-lap treatment can have a significant effect on human
tumor xenografts.
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Introduction
Certain chemotherapeutic drugs, such asmitomycin C [1–5],
tirapazamine (3-amino-1,2,4-benzotriazine 1,4-di-N-oxide;
SR4233) [6], E09 (3-hydroxy-5-aziridinyl-1-methyl-2-(1-
H-indole-4,7-dione)-prop-b-en-a-ol) [1,7], RH1 (3-hydroxy-
methyl-6-methyl-2,5(diaziridinyl)-1,4 benzoquinone) [1,8], and
b-lapachone (3,4-dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran-
5,6-dione; b-lap) [9–14], are prodrugs and become cytotoxic
to cancer cells following bioreduction. The major enzymes in-
volved in the bioreduction of quinone-containing drugs are as
follows: NAD(P)H:quinone oxidoreductase (NQO1), known as
DT-diaphorase; NAD(P)H:cytochrome P450 reductase, known
as P450R; and NADH:cytochrome b5 reductase, known as
b5R [1–16]. Whereas NQO1 mediates two-electron reduction,
P450R and b5Rmediate one-electron reduction of quinone com-
pounds. NQO1 is most abundant among the aforementioned
reductases in mammalian cells [1,9,14], and the level of NQO1
in many human tumors is much greater than that in adjacent
normal tissues [16–20]. Accordingly, there have been con-
siderable efforts to develop anticancer drugs that are acti-
vated specifically by NQO1 and, thus, are preferentially toxic to
tumors [1–5].
b-Lap, a quinone-containing compound originally obtained
from lapacho trees in South America, is a novel anticancer
drug, which has been demonstrated to possess strong cyto-
toxicity toward a variety of animal and human cancer cell lines
in vitro and in vivo [9–13,20–25]. It also synergistically kills
cancer cells when combined with paclitaxel (Taxol) [21–23],
ionizing radiation [13,24–27], and heat shock [28]. There have
been numerous hypotheses proposed and tested to determine
the mechanism of b-lap– induced cell death. The most recently
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proposed hypothesis is that NQO1 mediates a two-electron
reduction of b-lap using NADH and NAD(P)H as electron
sources [9–13,27,28]. The two-electron reduced form of
b-lap [i.e., b-lap (HQ)] is unstable and rapidly undergoes
reoxidation to the original b-lap, creating futile cycling be-
tween oxidized and reduced b-lap. As a consequence, when
cells are treated with b-lap, cellular NADH, NAD(P)H, and
adenosine triphosphate are severely depleted, and cyto-
plasmic Ca2+ is increased. This chaotic environment acti-
vates Ca2+-dependent calpain or similar proteases, resulting
in degradation of vital proteins, including p53 and poly(ADP-
ribose)polymerase (PARP), leading to caspase-independent
apoptosis [10–12]. However, under certain circumstances,
the two-electron reduced b-lap may be oxidized first to a one-
electron reduced intermediate (i.e., the semiquinone form
of b-lap), which then induces redox cycling and generates
reactive oxygen species (ROS), thereby causing caspase-
dependent apoptosis [10,23]. Bentle et al. [29] have recently
reported that b-lap treatment induces NQO1-dependent
ROS formation, Ca2+-dependent hyperactivation of PARP-1,
and DNA double-strand breaks indicated by an increase
in gH2AX foci formation. However, it was also hypothe-
sized that b-lap– induced apoptosis is due to the b-lap–
induced activation of cell cycle checkpoints resulting in
blockage of cell cycle progression [21–23]. Based on this
checkpoint activation hypothesis, phase I/II clinical trials
aiming to reveal the feasibility of using b-lap in combination
with other checkpoint-inhibiting drugs against human solid
tumors have recently been launched by a group of inves-
tigators [30].
Boothman et al. [24,25] and Boothman and Pardee [26]
reported that b-lap inhibits the repair of potentially lethal DNA
damage caused by radiation and enhances the various ef-
fects of radiation on cells. Using a split-irradiation method,
we observed that b-lap sensitizes cells to radiation by inhib-
iting the repair of sublethal radiation damage (SLD) [13,27].
In addition, we have previously observed that synergistic
cell death caused by b-lap and irradiation occurs even when
b-lap treatment was delayed by as long as 10 hours after
irradiation, at a time when most SLDs should have already
been repaired [13,27]. Importantly, ionizing radiation causes
a long-lasting elevation of NQO1 activity in cells [9,13,27].
These observations led us to hypothesize that the synergistic
cell death caused by ionizing radiation and b-lap treatment
results from inhibition of radiation damage repair and from
sensitization to b-lap exposure by radiation-induced upregu-
lation of NQO1 [13,27]. Related to this hypothesis, we have
observed that the exposure of cancer cells to mild heating at
41jC to 42jC for 1 hour increased NQO1 activity and cell
sensitivity to b-lap for over 24 hours after heating [28]. We
also observed that the growth of experimental tumors in
syngeneic mice could be significantly suppressed by com-
bining b-lap treatment with irradiation [13] or hyperthermia
[28]. These results clearly demonstrated that b-lap is a po-
tentially useful bioreductive drug, particularly in combination
with conventional cancer treatment regimens.
In our previous studies [13,27,28], we have used dicou-
marol [3-3Vmethylene-bis(4 hydroxycoumarin)], an inhibitor
of NQO1, to investigate the mechanism of NQO1 in b-lap–
induced cell death. Unfortunately, dicoumarol demonstrates
other activities besides antagonizing NQO1 function in cells.
Therefore, in the present study, we used siRNA-NQO1, in
addition to dicoumarol, to more rigorously test our hypothesis
on the relationship between the NQO1-mediated cytotoxic
effects and the NQO1-mediated radiosensitizing effects of
b-lap on A549 human lung epithelial cancer cells. We also
studied the kinetics of apoptosis development in A549 cells
after b-lap treatment and investigated DNA double-strand
breaks caused by b-lap alone or in combination with ionizing
radiation by examining gH2AX expression [31–33]. Lastly,
we studied the response of A549 xenograft tumors grown




A549 human lung cancer cells purchased from the Ameri-
can Type Culture Collection (Manassas, VA) were used. Cells
were cultured using Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% fetal calf serum (Hyclone
Laboratories, Inc., Logan, UT), penicillin (50 U/ml), and strep-
tomycin (50 mg/ml) at 37jC under a humidified 95% air–5%
CO2 atmosphere. All experiments were conducted using cells
in exponential growth phase by seeding cells into culture
flasks 15 to 18 hours before use. b-Lap purchased from a
commercial source (Sigma Chemical Co., St. Louis, MO) was
dissolved in dimethyl sulfoxide solution at 10 mM and diluted
to desired concentrations in a culture medium immediately
before use.
Clonogenic Cell Death By -Lap and Irradiation Alone
or in Combination
Cells were plated in 25-cm2 plastic T-type culture flasks
with 5 ml of complete DMEM, incubated overnight at 37jC,
and treated with b-lap for varying lengths of time at 37jC.
After washing twice with a culture medium, the cells were
incubated at 37jC with a complete medium for 8 to 9 days;
resultant colonies were fixed with a mixture of methanol and
acetic acid (10:1, vol/vol) and stained with 1% crystal violet.
The number of colonies containing > 50 cells was counted,
and the surviving fraction of clonogenic cells was calculated.
For the study of radiation effects on clonogenic survival, cells
were irradiated with a Cesium-137 irradiator (Model 68; J. L.
Shepherd and Associates, Glenwood, CA) at a dose rate of
0.9 Gy/min and incubated for 8 to 9 days; colonies were
counted; and the surviving fraction of clonogenic cells was
obtained. When cells were irradiated first and later treated
with b-lap, cells were maintained at 37jC during the interval
between the two treatments.
Effect of Dicoumarol and siRNA-NQO1
on -Lap Cytotoxicity
Effect of dicoumarol Cells were incubated with 50 mMdicou-
marol (NQO1 inhibitor; Sigma Chemical Co.) for 30 minutes
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and then treated with 5 mM b-lap for 4 hours at 37jC
[9,10,13,17]. As controls, cells were treated with b-lap alone
or with dicoumarol alone. After washing, the cells were
cultured for 8 to 9 days, and the surviving fraction of clono-
genic cells was calculated.
Effect of siRNA-NQO1 siRNA targetingNQO1 (National Cen-
ter for Biotechnology Information accession no. NM000903)
was synthesized by Ambion, Inc. (Austin, TX; Ambion ID
no. 212878). siRNA was 21 nucleotides long and contained
symmetric 3V overhangs of two deoxythymidines. A549 cells
were seeded in a 3.5-cm-diameter well of a six-well culture
plate (Sarstedt, Newton, NC) at a concentration of 4 105 cells
with 2 ml/well medium, incubated overnight, and transfected
with siRNA-NQO1. siRNA-NQO1 was diluted with a serum-
free medium to a final concentration of 100 nM, and siPORT
NeoFX was diluted with a serum-free medium at a ratio of 1:20
[34–36]. The diluted siRNA was mixed with the same volume
of diluted siPORT NeoFX (Ambion, Inc., Austin, TX) and in-
cubated for 10 minutes at room temperature. To each culture
well in which cells were seeded with 2 ml of medium, 200 ml of
the siRNA-NQO1 transfection mixture complex was added and
cultured for 48 hours at 37jC. Transfected cells were then
harvested, and their sensitivity to b-lap was investigated.
Western Blot Analysis
Cells were dissolved in solubilizing buffer [pH 7.4; 1%
Triton X-100, 0.1% sodium dodecyl sulfate (SDS), 20 mM
Tris–HCl, 150 mM NaCl, 1 mM EDTA, 1 mM sodium ortho-
vanadate, 1 mM sodium fluoride, 2 mM phenylmethane-
sulfonylfluoride, 10 mM iodoacetamide, 10 mg/ml aprotinin,
and 10 mg/ml leupeptin]. Aliquots containing 50 mg of pro-
tein were subjected to electrophoresis on 7.5% SDS poly-
acrylamide gel electrophoresis, and separated polypeptides
were transblotted onto Hybond-P (Amersham Life Sciences,
Arlington Heights, IL) in a transfer buffer (192 mM glycine,
25 mM SDS, and 10% methanol). Blots were then blocked
with 3% nonfat dry milk in Tris-buffered saline Tween-20
(pH 7.4) incubated with one of the following: anti-NQO1 anti-
body (1:1000 dilution; KOMA Biotech, Seoul, South Korea);
anti-p53 antibody (1:500 dilution; Calbiochem, San Diego,
CA); anti–NF-nB antibody (1:1000 dilution; Zymed, San
Francisco, CA); or anti–cytochrome C antibody (1:1000 di-
lution; UBI, Lake Placid, NY). The blots were then treated
with horseradish peroxidase–conjugated anti-mouse or anti-
goat IgG secondary antibody (1:1000 dilution; Santa Cruz
Biotech, Santa Cruz, CA), and immunoreactive bands were
visualized using chemiluminescence [13,37].
Caspase-3 Activity
Caspase-3 activity was determined using the BD ApoAlert
Caspase-3 Fluorescent Assay Kit (BD Biosciences Clontech,
Mountain View, CA). Briefly, cells were suspended in 1 ml of
lysis buffer on ice for 30 minutes and centrifuged at 15,000g
for 20 minutes at 4jC, and supernatants were collected. The
reaction buffer, consisting of 50 mM DEVD-AFC Asp-Glu-Val-
Asp-AFC fluorophore (caspase-3 substrate) and 2 mM dithio-
threitol, was added to the supernatants and then incubated at
37jC for 3 hours. Fluorescence from lysates was measured
with a fluorometer (Molecular Devices, Palo Alto, CA) with a
400-nm excitation filter and a 505-nm emission filter [34].
Gel Electrophoresis for Apoptotic DNA Fragmentation
Cells were treated overnight with lysis buffer [10 mM
Tris–HCl, pH 7.4; 10 mM NaCl; 10 mM EDTA; 0.1 mg/ml
proteinase K; and 1% (wt/vol) sodium dodecyl sulfate] at
48jC. A cold (4jC) 5-M NaCl solution was then added to
the lysate, vortexed for several seconds, and centrifuged at
10,000g for 5 minutes. The supernatant was mixed with
isopropanol (1:1) and incubated overnight at 20jC. After
centrifugation at 12,000g for 20 minutes, pellets were sus-
pended in TE buffer (10 mM Tris–HCl, pH 7.4; and 1 mM
EDTA), and RNA was digested by mixing with 0.2 mg/ml
DNase-free RNase. An aliquot of 15 to 20 mg of DNA from
each sample and a DNA molecular weight marker were
subjected to electrophoresis on a 1.5% agarose gel in TBE
(89 mM Tris base, 89 mM boric acid, and 2 mM EDTA) and
stained with ethidium bromide [37].
NQO1 Expression Study with Confocal Microscopy
Cells grown on tissue culture chamber slides were irradi-
ated with 4 Gy, rinsed with phosphate-buffered saline (PBS)
at various times thereafter, and fixed with a mixture of ace-
tone and methanol (1:1) for 20 minutes. After blocking with
1% bovine serum albumin, cells were incubated with anti-
NQO1 antibody (1:100 dilution in PBS; KOMA Biotech) for
2 hours, rinsed, and incubated for 1 hour with secondary
antibody (anti-mouse IgG) conjugated with fluorescein iso-
thiocyanate (FITC; Jackson ImmunoResearch, West Grove,
PA). Labeled cells were rinsed four times with PBS, and
NQO1 expression was assessed by visualizing with a laser
scanning confocal microscope [13].
NQO1 Enzyme Activity
Cells were washed twice with phenol red–free Hank’s
balanced salt solution, resuspended in PBS (pH 7.2) contain-
ing 10 mg/ml aprotinin, sonicated four times using 10-second
pulses on ice, and centrifuged at 14,000g for 20 minutes.
The resulting S9 supernatants were collected, transferred
into microcentrifuge tubes, and stored at 80jC until NQO1
enzyme activity has been assessed, as previously described
[10,13]. Briefly, the reaction medium contained 77 mM cyto-
chrome C (Sigma Chemical Co.) as substrate, 200 mM NADH
as immediate electron donor, 10 mM menadione as inter-
mediate electron acceptor, and 0.14% bovine serum albumin
in Tris–HCl buffer (50 mM, pH 7.5). Assays were initiated
by adding S9 supernatants to the reaction mixture, and en-
zyme activity was calculated as nanomoles of cytochrome
C reduced per minute per milligram of protein, based on the
initial rate of change in optical density at 550 nm, read with
a Beckman DU 640 spectrophotometer (Beckman Coulter,
Fullerton, CA). The extinction coefficient for cytochrome C
was 21.1 mM/cm at 37jC. Each assay was performed in the
presence and in the absence of dicoumarol, and the activity
that was reduced by dicoumarol was taken as NQO1 activity
[10,13,14,38].
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Flow Cytometric Analysis of Apoptosis
Cells were fixed overnight with 80% (vol/vol) ethanol at
4jC, centrifuged, washed with PBS, and resuspended in 2 ml
of PBS containing 30 U of DNase-free RNase. A 5-mg aliquot
of propidium iodide in 100 ml was added and incubated in the
dark at 37jC for 1 hour, and fluorescence was measured
using a FACSCalibur flow cytometer (Becton Dickinson,
San Jose, CA). The fraction of cells in sub-G1 phase (i.e.,
apoptotic cells and those in other cell cycle phases) was
estimated from cellular DNA content [37,39].
Determination of cH2AX Expression
Cellswereplated onLab-Tek chamber slides (Naperville, IL)
coated with 0.2% gelatin, incubated overnight at 37jC, and
treated with b-lap and irradiation alone or in combination. At
various times after treatment, cells were gently rinsed with
PBS and fixed with 4% paraformaldehyde for 20minutes. After
washing with PBS twice, cells were incubated with 1% bovine
serum albumin (BSA) in PBS for 1 hour and then with mono-
clonal anti-gH2AX antibody (1:500 dilution in 1% BSA; UBI) for
2 hours at 4jC. After washing twice in PBS, the cells were
treated with secondary antibody (anti-mouse IgG) conjugated
with FITC (1:500 dilution in 1% BSA; Jackson Immuno-
Research) for 1 hour at 37jC, and then washed with PBS
containing 0.1% Tween-20 (PBST). The cells were then
covered with cover slips using Vectashield mounting medium
(Vector Laboratories, Burlingame, CA), and gH2AX foci were
examinedwith a confocal fluorescent microscope. The number
of gH2AX foci in each cell was counted in > 60 cells from each
experimental group [31–33].
Antitumor Effect of -Lap
Tumor and -lap treatment Eight-week-old female athymic
(nu/nu) mice were obtained from Charles River Laboratories
(Wilmington, MA) and maintained in microisolator cages in
pathogen-free conditions, with laboratory chow andwater avail-
able ad libitum. A549 cells in exponential growth phase were
harvested from culture using trypsin treatment and washed,
and 6  106 cells in 0.1 ml were injected subcutaneously into
the right hind leg of each mouse. Two weeks later, when the
tumors had grown to 80 to 120 mm3, they were irradiated
with 10-Gy X-rays in a single exposure, and host mice were
immediately injected intraperitoneally with 50 mg/kg b-lap
dissolved in 0.2 ml of b-hydroxypropyl-b-cyclodextrin (Sigma
Chemical Co.). The effects of 10-Gy irradiation or b-lap alone
on tumor growth were also studied. Tumor diameters were
measured with a caliper, and tumor volumes were obtained
using the formula: V = a2b/2, where a is the shortest tumor
diameter and b is the longest tumor diameter. Mice were
euthanized by CO2 aspiration when tumor volume had reached
1.5 cm3. All tumor experiments were performed following the
protocol approved by the University of Minnesota Institutional
Animal Care Use Committee (protocol no. 0112A13064).
X-irradiation of tumors Mice were anesthetized with an
intraperitoneal injection of a mixture of 100 mg/kg ketamine
and 10 mg/kg xylazine. With the exception of tumor-bearing
legs, mice were covered with a 4-mm-thick lead shield, and
tumors were irradiated with 250-kVp orthovoltage X-rays
with added filtration of 0.35 mm of Cu (Philips Medical
System, Brookfield, WI) at a dose rate of 1.4 Gy/min.
Statistical Analysis
Two-tailed Student’s t test was used to determine the
statistical significance of all data sets.
Results
Effect of -Lap on Clonogenic Cell Survival
As shown in Figure 1A, treating A549 human lung cancer
cells with 5 mM b-lap decreased clonogenic cell survival as
Figure 1. Effect of -lap alone or in combination with irradiation on the survival
of A549 cells. (A) Survival curve of A549 cells treated with 5 M -lap for
various lengths of time. A549 cells were treated with 5 M -lap for 4 to
24 hours at 37jC and cultured for 7 to 9 days, and surviving fractions were
calculated. The averages of seven experiments with 1 SE are shown. (B) Sur-
vival curve of A549 cells treated with different concentrations of -lap for
varying lengths of time. Cells were treated with 2 to 10 M -lap for 4 to
24 hours at 37jC and cultured for 7 to 9 days, and surviving fractions were
calculated. The averages of seven experiments with 1 SE are shown. (C) Sur-
vival curves of cells treated with radiation alone or in combination with -lap.
Cells were treated with different doses of radiation alone (RT only) or irradiated
and immediately incubated with 5 M -lap for 4 hours (-lap 5 M + RT). The
cells were then cultured for 7 to 9 days, and surviving fractions were calculated.
The survival curve for the combined treatment was normalized for cell deaths
caused by -lap alone. The averages of seven experiments with 1 SE are
shown. (D) Effects of -lap treatment applied at different times after the irra-
diation of cells. Cells were treated with 4-Gy radiation alone (4 Gy) at 4-hour
incubation with 5 M -lap alone (-lap), or irradiated with 4 Gy and treated
with 5 M -lap for 4 hours at different times after irradiation (4 Gy + -lap).
Cells were then incubated for 7 to 9 days, and surviving fractions were cal-
culated. The averages of six experiments with 1 SE are shown. The dotted line
corresponds to a hypothetical cell survival when the combined effect of 4-Gy
irradiation and 5 M -lap treatment is assumed to be additive.
B-Lapachone and Radiosensitivity Choi et al. 637
Neoplasia . Vol. 9, No. 8, 2007
a function of incubation time: incubation for 4 and 8 hours
reduced clonogenic survival to about 10% and 1.0%, re-
spectively. Figure 1B shows clonogenic cell death caused
by a 4-hour treatment with different concentrations of b-
lap. Treatment with 2.5 mM b-lap for 4 hours caused little
change in cell survival; however, treatment with 5 and 7.5 mM
b-lap for 4 hours decreased cell survival to about 10% and
1.0%, respectively.
Combined Effect of -Lap and Irradiation
on Clonogenic Cell Survival
Figure 1C shows the survival curve of A549 cells treated
with radiation alone or of cells irradiated first and then imme-
diately exposed to 5 mM b-lap for 4 hours. The radiation–
survival curve of cells treated with irradiation immediately
followed by b-lap treatment, particularly in the initial shoulder
region, was steeper than that of cells receiving irradiation
alone. This result suggested that repair of SLD is reduced
when irradiated cells are immediately treated with b-lap. The
combined effect of the two modalities was further elucidated
by irradiating the cells with 4 Gy and then treating the cells
with 5 mM b-lap for 4 hours at various times after irradiation.
As presented in Figure 1D, the clonogenic cell death caused
by irradiation immediately followed by a 4-hour incubation
with b-lap treatment was significantly greater than the cell
death expected to occur had the two modalities acted merely
additively (dotted line) (P < .05). The survival of cells that
were irradiated first and then treated with b-lap decreased
even further as the time interval between irradiation and b-lap
treatment was increased to 4, 16, or 24 hours.
Effect of Irradiation on NQO1 Activity
Both immunostaining of cells (Figure 2A) and Western
blot analysis (Figure 2B) showed that a considerable amount
of constitutive NQO1 exists in A549 cells and that 4-Gy
irradiation caused a significant increase in NQO1 expres-
sion for 2 to 24 hours. The enzyme activity of NQO1 before
irradiation, as determined by the amount of NQO1-induced
reduction in cytochrome C [10,13], was 9.5 ± 1.3 mmol of
cytochrome C reduced per minute per milligram of pro-
tein. NQO1 activity progressively increased, reaching about
1.5-fold of the control value 16 to 24 hours after 4-Gy irra-
diation (Figure 2C).
Suppression of -Lap Cytotoxicity By Dicoumarol
and siRNA-NQO1
Figure 3A shows that a 4-hour incubation with 50 mM
dicoumarol, an inhibitor of NQO1, exerted little effect on
clonogenic cell survival. When cells were incubated with
10 mM b-lap for 4 hours, 0.51 ± 0.18% of cells survived,
whereas as much as 25.9 ± 2.9% of cells survived when
cells were incubated with 10 mM b-lap and 50 mM dicou-
marol. A 4-hour incubation with 50 mM dicoumarol starting
immediately after 4-Gy irradiation exerted no influence on
radiation-induced cell death. Irradiation with 4 Gy followed
by a 4-hour incubation with 10 mM b-lap reduced cell survival
to 0.09 ± 0.05%, whereas irradiation with 4 Gy followed by
a 4-hour incubation with 10 mM b-lap, together with 50 mM
dicoumarol, reduced cell survival to 14.5 ± 3.0%. Pertinent to
this observation is that NQO1 activity in A549 cells treated
with 50 mM dicoumarol for 4 hours was about 74% that of
control cells (data not shown). Figure 3B shows that trans-
fection with siRNA-NQO1 exerted no effect on clonogenic
cell survival, whereas siRNA-NQO1 significantly reduced the
cytotoxicity of b-lap. The survival of cells transfected with
siRNA-NQO1 was about three-fold greater than that of non-
transfected cells after treatment with 5 mM b-lap for 4 hours.
Effects of -Lap on the Expression of p53 and NF-jB,
and on the Release of Cytochrome C
Figure 4 shows the effect of a 4-hour incubation of cells with
5 mM b-lap on the expression of p53 and NF-nB, and on the
release of cytochrome C. p53 expression markedly declined
immediately after b-lap treatment and had almost completely
vanished by 16 hours (i.e., 12 hours after b-lap treatment).
NF-nB expression immediately after b-lap treatment was sig-
nificantly less than that before treatment, but it slightly recov-
ered at 16 hours. The release of cytochrome C increased
Figure 2. Effects of radiation on the expression and enzymatic activity of
NQO1 in A549 cells. (A) NQO1 expression at various times after 4-Gy irra-
diation in A549 cells. Control and irradiated cells were labeled with anti-NQO1
antibody, followed by labeling with secondary antibody conjugated with FITC
and examined with confocal microscopy. (B) Typical example of Western
blot analysis for NQO1 at various times after 4-Gy irradiation in A549 cells.
The cells were dissolved in solubilizing buffer, and lysates were subjected to
Western blot analysis. Blots from control and irradiated cells were labeled
with anti-NQO1 antibody and then with horseradish peroxidase–conjugated
secondary antibody, and immunoreactive bands were visualized using chemi-
luminescence. (C) Enzymatic activity of NQO1 at various times after 4-Gy
irradiation in A549 cells. Control and irradiated cells were sonicated, and
enzyme activity in S9 supernatants was determined. The enzyme activity in
irradiated cells relative to that in control cells (9.5 ± 1.3 mol of cytochrome C
reduced per minute per milligram of protein) is shown. The averages of six
experiments with 1 SE are shown.
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markedly immediately after b-lap treatment, but progressively
decreased from 4 to 20 hours after b-lap treatment.
Effect of -Lap on Caspase-3 Activity
Relative changes in caspase-3 activity are presented in
Figure 4B. Caspase-3 activity was slightly increased im-
mediately after a 4-hour incubation with 5 mM b-lap and in-
creased further to about four times that of control at 8 hours
(i.e., 4 hours after b-lap treatment; P > .05). Caspase-3
activity then slowly decreased to about 2.5-fold higher than
that of control by 24 hours after b-lap exposure.
Apoptosis Caused By -Lap Alone or in Combination
with Irradiation
As shown in Figure 5A, a significant degree of apoptotic
DNA fragmentation could be seen immediately after a 4-hour
incubation with 5 mM b-lap, which progressively increased
thereafter. On the contrary, no significant DNA fragmentation
was observed by 24 hours after 4-Gy irradiation. The degree
of DNA fragmentation in cells that were exposed to b-lap
and irradiated with 4 Gy was similar to that in cells exposed
to b-lap alone. Figure 5B shows changes in the percentage
of apoptotic cells after b-lap treatment, which was obtained
based on DNA content as measured with the flow cytometry
method. The apoptotic cell population (i.e., cells in sub-G1
phase) progressively increased after a 4-hour incubation
with 5 mM b-lap. About 78% of cells were apoptotic at
24 hours (i.e., 20 hours after b-lap treatment).
Effects of -Lap and Radiation on cH2AX
Irradiation of A549 cells with 2 Gy significantly increased
the formation of gH2AX foci (a hallmark of DNA double-
strand break detection by cells) within 1 hour of exposure
(P < .05). The gH2AX foci formation immediately after treat-
ment with 2 mM b-lap for 1 hour was only slightly elevated
(Figure 6, A and B), although it significantly increased at
4 hours after treatment (data not shown). The gH2AX foci
formation in cells exposed to 2-Gy irradiation and treated
with 2 mM b-lap for 1 hour was slightly greater than that in
cells treated with irradiation alone.
Figure 3. Effects of dicoumarol or siRNA-NQO1 on -lap– induced clono-
genic death in A549 cells. (A) Effects of dicoumarol: Dic—cells were treated
with 50 M dicoumarol for 4 hours; -lap—cells were treated with 10 M
-lap for 4 hours; -lap + Dic—cells were treated with 10 M -lap plus 50 M
dicoumarol for 4 hours; 4 Gy—cells were irradiated with 4 Gy; 4 Gy + Dic—
cells were irradiated and then treated with 50 M dicoumarol for 4 hours;
4 Gy + -lap—cells were irradiated with 4 Gy and immediately incubated with
10 M -lap for 4 hours; 4 Gy + -lap + Dic—cells were irradiated with 4 Gy
and immediately treated with 10 M -lap plus 50 M dicoumarol for 4 hours.
Cells were washed after the treatments and incubated for 7 to 9 days, and
surviving fractions were calculated. The averages of six experiments with
1 SE are shown. (B) Effects of siRNA-NQO1: siRNA-NQO1—cells trans-
fected with siRNA-NQO1 were incubated with regular medium for 4 hours;
-lap—cells were incubated with 5 M -lap for 4 hours; siRNA-NQO1 +
-lap—cells transfected with siRNA-NQO1 were incubated with 5 M -lap
for 4 hours. After the treatments, cells were washed and incubated for 7 to
9 days, and surviving fractions were calculated. The averages of four experi-
ments with duplicate cultures with 1 SE are shown.
Figure 4. Changes in the expression of p53 and NF-jB, release of cyto-
chrome C, caspase-3 activity and DNA laddering by -lap, or radiation expo-
sure in A549 cells. (A) Cells were treated with 5 M -lap for 4 hours,
harvested at different times, and washed. The cells were then dissolved in
solubilizing buffer, and lysates were subjected to Western blot analysis. The
hours shown are those from the start of a 4-hour -lap incubation. Thus,
‘‘4 hours’’ implies 0 hour after 4 hours of incubation with -lap. The result
shown is representative of five individual experiments. (B) Cells were treated
with 5 M -lap for 4 hours, harvested, washed, and lysed. Caspase-3 activity
was determined using a commercially available assay kit (see text). Relative
changes in caspase-3 activity are shown. The hours shown are those from
the start of a 4-hour incubation with -lap. The averages of five measure-
ments with 1 SE are shown.
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Tumor Growth
The relative volume of A549 tumors as a function of days
after treatment is shown in Figure 7. Tumor growth was
slightly suppressed by a single intraperitoneal injection of
50 mg/kg b-lap and was noticeably suppressed by a single
10-Gy irradiation. However, tumor growth was markedly sup-
pressed when the tumors were first irradiated with 10 Gy and
the host mice were subsequently injected intraperitoneally
with 50 mg/kg b-lap. The volume of control and that of b-lap–
treated tumors increased four times in 15.2 ± 1.7 and 15.4 ±
2.4 days, respectively, and the volume of irradiated tumors
increased four times in 16.8 ± 1.4 days. The volume of tu-
mors receiving the combined treatment increased four times
in 25.7 ± 3.5 days, which was nearly 10 days longer than
that caused by irradiation or b-lap treatment alone (P < .05).
Discussion
We have demonstrated that the combination of irradiation
with the bioreductive drug b-lap effectively kills A549 human
lung cancer cells in vitro and also suppresses the growth of
A549 xenografts—a result that has not been reported yet in
human tumor models. Treatment of A549 cells with b-lap
alone in vitro caused clonogenic cell death (Figure 1, A and
B) and rapid apoptosis (Figure 5). Furthermore, b-lap syner-
gistically interacted with ionizing radiation in causing clono-
genic cell death (Figure 1, C and D). Killing of A549 cells by
b-lap alone or in combination with radiation could be sig-
nificantly suppressed with dicoumarol, an inhibitor of NQO1
(Figure 3A), indicating that NQO1 is an important mediator
of cell death caused by b-lap alone or in combination with
ionizing radiation. Dicoumarol is not specific against NQO1
[40] and, thus, it was possible that dicoumarol reduced the
cytotoxicity of b-lap through mechanisms other than inhibi-
tion of NQO1 activity. Therefore, we further investigated
the role of NQO1 in b-lap– induced cell death using siRNA-
NQO1 to transiently suppress NQO1 expression in A549
cells. As shown in Figure 3B, siRNA-NQO1 could signifi-
cantly reduce the effect of b-lap to cause clonogenic cell
death. These results clearly demonstrated that NQO1 is a
critical determinant for cell deaths caused by b-lap alone
and in combination with irradiation in A549 human lung can-
cer cells.
It has been suggested that futile cycling between an
oxidized and a two-electron reduced form of b-lap, mediated
by NQO1 and requiring NADH and NAD(P)H as electron
Figure 5. Apoptosis caused by -lap alone or in combination with irradiation in
A549 cells. (A) -Lap—cells were treated with 5 M -lap for 4 hours; -lap +
4 Gy—cells were irradiated with 4 Gy and immediately incubated with 5 M
-lap for 4 hours; 4 Gy—cells were irradiated with 4 Gy. Cells were washed,
lysed, and subjected to agarose electrophoresis for detection of DNA frag-
mentation. The times shown for -lap treatment groups are hours from the
start of a 4-hour incubation with -lap. (B) Percentage of apoptotic cells after
a 4-hour incubation with 5 M -lap. Apoptosis was determined with flow
cytometry method. The cells in sub-G1 phase were taken as apoptotic cells.
The hours indicate the time from the start of a 4-hour incubation with -lap.
The averages of four experiments with 1 SE are shown.
Figure 6. Effects of irradiation and -lap alone or combined on cH2AX foci
formation in A549 cells. (A) Upper panel: cH2AX foci expression in
representative cells from each experimental group; lower panel: the nucleus
of corresponding cells stained with 4 V,6-diamidino-2-phenylindole. (a) Con-
trol cells; (b) 1-hour treatment with 2 M -lap; (c) 1 hour after 2-Gy irradia-
tion; (d) 2-Gy irradiation followed by 1-hour incubation with 2 M -lap.
(B) Number of cH2AX foci per cell. (a) Control cells; (b) 1-hour treatment with
2 M -lap; (c) 1 hour after 2-Gy irradiation; (d) 2-Gy irradiation followed by
1-hour incubation with 2 M -lap. The averages of four experiments with
1 SE are shown.
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sources, causes depletion or oxidation of NADH and
NAD(P)H, resulting in activation of Ca2+-dependent calpain
or similar proteases [11,12,29,41]. In cells treated with b-lap,
vital proteins such as p53 and PARP were found to be de-
graded, probably due to the b-lap– induced activation of cal-
pain or similar proteases [11,12,29]. As shown in Figure 4A,
we also observed that b-lap treatment markedly reduced p53
expression in A549 human lung cancer cells. It has been
previously reported that p53 is stabilized by NQO1 and, thus,
inhibition of NQO1 led to degradation of p53 [42]. It may then
be hypothesized that b-lap, a substrate of NQO1, deprives
NQO1 of its ability to protect p53 from calpain or similar pro-
teases. We are currently testing this hypothesis by studying
the effect of calpain inhibitors on b-lap– induced down-
regulation of p53. As shown in Figure 5, as much as 60%
to 80% of cells were already apoptotic at 16 to 24 hours after
b-lap treatment. It is, therefore, probable that the lack of p53
expression 16 to 24 hours after b-lap treatment (Figure 3A)
was due to apoptotic disintegration of cells. Massive release
of cytochrome C and inactivation of NF-nB (Figure 4A) may
account for the activation of caspase-3 and the rapid induc-
tion of apoptosis after b-lap exposure, as determined with
the DNA laddering method (Figure 5A) and the flow cytome-
try method (Figure 5B). However, activation of caspase-3
in A549 cells by b-lap treatment is at odds with other reports
[9–12,29] indicating that the effect of b-lap on p53 expres-
sion may be dependent on cell line.
The slope of the initial part of the radiation–survival curve of
cells irradiated and immediately treated with b-lap was steeper
than that of cells receiving irradiation only (Figure 1C), which
indicates that b-lap increased the radiosensitivity of cells. With
the use of split-dose irradiation, we have previously demon-
strated that b-lap inhibits SLD repair in rodent cancer cell lines
[13,27]. Inhibition of SLD repair may account for the greater-
than-additive clonogenic cell death that occurs when cells are
irradiated and immediately treated with b-lap (0-hour interval
between 4-Gy irradiation and b-lap treatment, as shown in
Figure 1D). However, inhibition of SLD repair by b-lap could not
account for the synergistic cell death caused by irradiation and
b-lap treatment applied 4 to 24 hours after irradiation because
repair of SLD is usually completed in 2 to 4 hours. This ob-
servation supports our hypothesis [13,27] that the synergistic
cell death caused by exposure to radiation and b-lap treatment
applied 4 to 24 hours later is due to a long-lasting upregulation
of NQO1 caused by radiation exposure.
It has been demonstrated that DNA double-strand breaks
lead to phosphorylation of H2AX at serine 139, thereby
forming gH2AX [31–33]. As shown in Figure 6, significant
gH2AX foci formation could be observed immediately after
2-Gy irradiation in A549 cells. However, gH2AX foci forma-
tion was negligible when examined immediately after treat-
ment with 2 mM b-lap for 1 hour, although significant gH2AX
foci formation was observed 4 hours after a 1-hour treatment
with 2 mM b-lap (data not shown), which indicates that b-lap is
a potent inducer of DNA DSB, as recently reported by other
investigators [29]. The gH2AX foci formation in cells irradi-
ated with 2 Gy and treated with 2 mM b-lap for 1 hour was
slightly greater than that in cells receiving irradiation alone.
However, the combined effect of 2 Gy irradiation and 1-hour
treatment with 2 mM b-lap on increasing gH2AX foci formation
appeared to be no more than additive. The specific relation-
ship between gH2AX formation and induction of apoptosis
caused by b-lap treatment alone or in combination with irra-
diation remains to be elucidated further.
In contrast to our previous results in rodent tumors [13],
a single b-lap treatment at 50 mg/kg alone exerted little ef-
fect on the growth of A549 human tumor xenografts in the
present study. However, combined treatment with irradia-
tion and b-lap suppressed the growth of A549 human lung
tumor xenografts to a greater-than-additive extent (Figure 7).
It should be noted that radiation-induced upregulation of
NQO1 and the resulting increase in b-lap toxicity, as seen
in our in vitro studies (Figure 1D), probably did not play a
significant role in the synergistic antitumor effect in the
present in vivo study because b-lap treatment was adminis-
tered immediately after tumor irradiation and, thus, b-lap
was likely cleared before radiation-induced upregulation of
NQO1 became significant. Therefore, we suspect that syn-
ergistic suppression of tumor growth was due mostly to
b-lap–induced radiosensitization rather than to an increase
in direct b-lap toxicity mediated by NQO1. The effect of b-lap
injections several hours after tumor irradiation, as well as the
effect of multiple b-lap injections, is currently being studied
in our laboratory.
We conclude that NQO1 is an important player in cell death
caused by the naturally occurring product b-lap and that
ionizing radiation synergistically increases b-lap– induced
clonogenic cell death by upregulating NQO1. Lastly, b-lap
increases cellular radiosensitivity by inhibiting SLD repair.
Importantly, our results clearly demonstrate for the first
time that combined radiation and b-lap therapy has a signifi-
cant antitumor effect on human tumor xenografts. Therefore,
Figure 7. Effects of various treatments on the growth of A549 human lung
tumor xenografts in the hind legs of nude mice. 10 Gy—tumors were locally
irradiated with 10 Gy in a single exposure; 50 mg/kg -lap—the host mice
were injected intraperitoneally with -lap at 50 mg/kg; 10 Gy + 50 mg/kg
-lap—tumors were locally irradiated with 10 Gy in a single exposure and
then the host mice were injected intraperitoneally with -lap at 50 mg/kg. The
averages of five to seven tumors per group with 1 SE are shown.
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further study of this therapeutic mechanism is warranted
considering that NQO1 levels in many human tumors have
been documented to be much higher than those in adjacent
normal tissues [1,2,16–20]. It may also be valuable to inves-
tigate the feasibility of specifically exploiting radiation-induced
NQO1 activity to enhance the cytotoxicity of bioreductive
drugs other than b-lap, such as mitomycin C.
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